ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nextech Named 2024 Best in KLAS: Ambulatory Specialty EHR

TAMPA, Fla., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Nextech, a leading provider of clinical and administrative healthcare technology solutions for specialty physician practices, today announced its EHR software is a top-ranked solution in the 2024 Best in KLAS®: Software & Services report. Client-driven evaluations and feedback rated Nextech as the No. 1 company in the Ambulatory Specialty EHR category.

The Best in KLAS report lists the year's top-performing medical software and services companies based on excellence in helping healthcare professionals improve patient care. Rankings are determined by in-depth interviews of thousands of providers conducted by independent KLAS researchers, providing accurate and impartial insights on each company's level of commitment and partnership.

“At KLAS, we firmly believe that the voice of healthcare providers and payers is paramount. The Best in KLAS awards are based on extensive feedback and evaluations from healthcare professionals across the nation,” said Adam Gale, KLAS Research CEO. “Winning a Best in KLAS award, therefore, is not just about recognition; it shows the trust and confidence that healthcare providers place in the winning vendors. It also helps validate each vendor’s commitment to innovation, quality, and customer satisfaction. We are proud to recognize 2024’s Best in KLAS award winners! Their unwavering dedication to improving patient outcomes is wonderfully inspiring.”

Nextech CEO Bill Lucchini noted how this recognition highlights how providers have the utmost confidence in Nextech's ability to help them overcome myriad challenges in a dynamic healthcare environment.

“The work our clients do in delivering excellent patient experiences and healthcare outcomes inspires us at Nextech to push even harder to deliver innovative solutions that help make the work of caring for patients easier, faster, and better,” Lucchini said. “Being named Best in KLAS is that much more special knowing that it’s driven by healthcare professionals. Their confidence in us is gratifying, and we work to continue to earn that confidence every day.”

Nextech's EHR and practice management solution simplifies how providers deliver excellent patient care and advance business growth. Nextech's software is uniquely designed to address the most complex challenges specialty practices face. It streamlines the day-to-day routine with time-saving charting features, adaptable templates, intuitive workflows, and built-in point-of-sale functionality that enhances recurring revenue opportunities.

To learn more about Nextech's solution and its features, visit https://www.nextech.com.

About Nextech

Nextech is the complete healthcare technology solution for specialty providers. Since 1997, Nextech has been focused on delivering innovative solutions and services that drive efficiency, fuel growth, and enhance the patient care experience. Nextech services more than 16,000 physicians and over 60,000 office staff members in the clinical specialties of Dermatology, Med Spa, Ophthalmology, Orthopedics, and Plastic Surgery.

Chris Farrell  

VP, Marketing  

(813) 998-4229  

 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.